Literature DB >> 11142426

Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.

C M Ulrich1, J Bigler, C M Velicer, E A Greene, F M Farin, J D Potter.   

Abstract

Databases of expressed sequence tags (EST) can be used to screen rapidly for potential polymorphisms in candidate proteins. As part of this study, we screened the gene for the enzyme thymidylate synthase (TS). TS is important physiologically because it is essential for the synthesis of deoxythymidylate, a nucleotide required for DNA synthesis and repair. TS is also a major target for cancer chemotherapeutic drugs, especially the widely used 5-fluorouracil. Using sequence alignment of ESTs, we identified a candidate 6-bp variation at bp 1494 in the 3'-untranslated region of the TS mRNA. This sequence variation occurred in 21 of 34 aligned ESTs at this location, including ESTs from various tissue sources. The presence of this polymorphism was confirmed in a Caucasian population (n = 95) by polymerase chain restriction amplification/RFLP analysis. The allele frequency of the 6-bp deletion was found to be 0.29 (wildtype +6 bp/+6 bp, 48%; +6 bp/-6 bp, 44%; -6 bp/-6 bp, 7%). Although the function of this polymorphism has not yet been investigated, the 3'-untranslated region of a gene can play a role in mRNA stability and translation. This study illustrates an approach to polymorphism discovery in candidate enzymes of physiological interest by searches of publicly available sequence data, a rapid and inexpensive method. The potential functional relevance of the common 6-bp deletion in the TS gene needs to be investigated, because this enzyme is plausibly of major importance not only in cancer treatment but also in cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142426

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  62 in total

Review 1.  Part 1: background, methodology, and clinical adoption of pharmacogenetics.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

2.  Pharmacogenetics: implementing personalized medicine.

Authors:  Enrico Mini; Stefania Nobili
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

3.  Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance.

Authors:  Jingfang Ju
Journal:  Curr Enzym Inhib       Date:  2012-09-01

Review 4.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

5.  Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer.

Authors:  Wen Zhuang; Xiao-Ting Wu; Yong Zhou; Guan-Jian Liu; Tai-Xiang Wu; Xun Yao; Liang Du; Mao-Ling Wei
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

6.  Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Authors:  Aurea Lima; Vítor Seabra; Sandra Martins; Ana Coelho; António Araújo; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2014-02-20       Impact factor: 2.316

7.  Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease.

Authors:  N Düzgün; T Duman; Y Morris; H Tutkak; K Köse; E Ertuğrul; O Tiryaki Aydintuğ
Journal:  Clin Rheumatol       Date:  2008-05-06       Impact factor: 2.980

8.  Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.

Authors:  Maki Inoue; Kim Robien; Renwei Wang; David J Van Den Berg; Woon-Puay Koh; Mimi C Yu
Journal:  Carcinogenesis       Date:  2008-07-31       Impact factor: 4.944

9.  Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.

Authors:  Linda E Kelemen; Thomas A Sellers; Joellen M Schildkraut; Julie M Cunningham; Robert A Vierkant; V Shane Pankratz; Zachary S Fredericksen; Madhura K Gadre; David N Rider; Mark Liebow; Ellen L Goode
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

10.  In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs).

Authors:  C Sudandiradoss; Rao Sethumadhavan
Journal:  Genomic Med       Date:  2009-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.